Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chalcogen Weak Interaction Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112608269B introduces a mild chalcogen weak interaction method for pyrrolidine synthesis, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.